ABOS
Price
$1.24
Change
+$0.01 (+0.81%)
Updated
Jun 26, 12:49 PM (EDT)
Capitalization
74.51M
53 days until earnings call
XBIT
Price
$2.89
Change
+$0.23 (+8.65%)
Updated
Jun 26, 01:43 PM (EDT)
Capitalization
81.1M
50 days until earnings call
Interact to see
Advertisement

ABOS vs XBIT

Header iconABOS vs XBIT Comparison
Open Charts ABOS vs XBITBanner chart's image
Acumen Pharmaceuticals
Price$1.24
Change+$0.01 (+0.81%)
Volume$233
Capitalization74.51M
XBiotech
Price$2.89
Change+$0.23 (+8.65%)
Volume$1.14K
Capitalization81.1M
ABOS vs XBIT Comparison Chart in %
Loading...
ABOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XBIT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABOS vs. XBIT commentary
Jun 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABOS is a StrongBuy and XBIT is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 26, 2025
Stock price -- (ABOS: $1.23 vs. XBIT: $2.66)
Brand notoriety: ABOS and XBIT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABOS: 137% vs. XBIT: 141%
Market capitalization -- ABOS: $74.51M vs. XBIT: $81.1M
ABOS [@Biotechnology] is valued at $74.51M. XBIT’s [@Biotechnology] market capitalization is $81.1M. The market cap for tickers in the [@Biotechnology] industry ranges from $114.49B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABOS’s FA Score shows that 0 FA rating(s) are green whileXBIT’s FA Score has 1 green FA rating(s).

  • ABOS’s FA Score: 0 green, 5 red.
  • XBIT’s FA Score: 1 green, 4 red.
According to our system of comparison, XBIT is a better buy in the long-term than ABOS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABOS’s TA Score shows that 5 TA indicator(s) are bullish while XBIT’s TA Score has 4 bullish TA indicator(s).

  • ABOS’s TA Score: 5 bullish, 4 bearish.
  • XBIT’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, ABOS is a better buy in the short-term than XBIT.

Price Growth

ABOS (@Biotechnology) experienced а +0.82% price change this week, while XBIT (@Biotechnology) price change was +2.31% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.78%. For the same industry, the average monthly price growth was +31.36%, and the average quarterly price growth was +15.04%.

Reported Earning Dates

ABOS is expected to report earnings on Aug 18, 2025.

XBIT is expected to report earnings on Aug 15, 2025.

Industries' Descriptions

@Biotechnology (+1.78% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
XBIT($81.1M) has a higher market cap than ABOS($74.5M). ABOS YTD gains are higher at: -28.488 vs. XBIT (-32.658). XBIT has higher annual earnings (EBITDA): -36.99M vs. ABOS (-111.98M). XBIT (156M) and ABOS (149M) have equal amount of cash in the bank . XBIT has less debt than ABOS: XBIT (10M) vs ABOS (29M). ABOS (0) and XBIT (0) have equivalent revenues.
ABOSXBITABOS / XBIT
Capitalization74.5M81.1M92%
EBITDA-111.98M-36.99M303%
Gain YTD-28.488-32.65887%
P/E RatioN/AN/A-
Revenue00-
Total Cash149M156M96%
Total Debt29M10M290%
FUNDAMENTALS RATINGS
XBIT: Fundamental Ratings
XBIT
OUTLOOK RATING
1..100
59
VALUATION
overvalued / fair valued / undervalued
1..100
74
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
86
P/E GROWTH RATING
1..100
5
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ABOSXBIT
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 3 days ago
77%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
74%
Momentum
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
84%
MACD
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
69%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 3 days ago
77%
Bullish Trend 3 days ago
67%
Declines
ODDS (%)
Bearish Trend 16 days ago
88%
Bearish Trend 9 days ago
83%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
75%
Aroon
ODDS (%)
Bullish Trend 2 days ago
71%
Bearish Trend 2 days ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
ABOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XBIT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NVNO4.220.06
+1.44%
enVVeno Medical Corp
NINOY9.70-0.01
-0.15%
Nikon Corp.
BBKCF0.09N/A
-0.23%
BIGG Digital Assets Inc.
CRARY9.13-0.03
-0.38%
Credit Agricole SA
SMPNY14.42-0.24
-1.64%
Sompo Hldgs Inc

ABOS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABOS has been loosely correlated with FHTX. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if ABOS jumps, then FHTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABOS
1D Price
Change %
ABOS100%
-2.38%
FHTX - ABOS
55%
Loosely correlated
+0.62%
CRBU - ABOS
52%
Loosely correlated
+0.71%
BEAM - ABOS
50%
Loosely correlated
-2.27%
CRSP - ABOS
48%
Loosely correlated
+1.88%
GLSI - ABOS
48%
Loosely correlated
-0.55%
More

XBIT and

Correlation & Price change

A.I.dvisor indicates that over the last year, XBIT has been loosely correlated with GLSI. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if XBIT jumps, then GLSI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XBIT
1D Price
Change %
XBIT100%
-0.37%
GLSI - XBIT
42%
Loosely correlated
-0.55%
GBIO - XBIT
41%
Loosely correlated
-1.51%
NAUT - XBIT
40%
Loosely correlated
+10.50%
ABOS - XBIT
39%
Loosely correlated
-2.38%
TECH - XBIT
38%
Loosely correlated
+3.78%
More